December 21, 2011

Drug may be first to halt Alzheimer's progression

A new medication may actually halt the progression of Alzheimer's disease, investigators have found. When given to mice with Alzheimer's, the drug, known as J147, improved memory and prevented brain damage caused by the disease. The new compound, developed by scientists at the Salk Institute for Biological Studies, could soon be tested on humans. Currently, only medications that slow the diseases' progression have received federal approval. Full findings appear in PLoS ONE.


Similar Articles
Related Topics

More in Products

HealthLease purchase completed

CFG Capital Markets, the investment banking platform of Capital Funding Group, announced it was an advisor on a $141.7 million portfolio.

Bulk TV & Internet announce partnership

Bulk TV & Internet has become an authorized partner of Mitel, a provider of cloud and premises-based unified communications and collaboration software.

Oak Grove Capital closes line for Brookdale

Oak Grove Capital announced it has closed a $259 Fannie Mae DUS credit facility for Brookdale Senior Living.